C. Yolland

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

A. Harris, M. Berk, F. Dark, 2022, Schizophrenia bulletin.

Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review

Paul S. Francis, A. Harris, D. Castle, 2018, Nutritional neuroscience.

Does the clozapine/norclozapine ratio predict cognitive performance in patients with clozapine-resistant schizophrenia?

A. Harris, C. Galletly, S. Rossell, 2021, The Australian and New Zealand journal of psychiatry.

Valuing the voice of lived experience of eating disorders in the research process: Benefits and considerations

S. Miles, Z. Jenkins, A. Phillipou, 2021, The Australian and New Zealand journal of psychiatry.

Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia

A. Harris, M. Berk, D. Castle, 2019, The Australian and New Zealand journal of psychiatry.

Non-visual hallucinations in Parkinson’s disease: a systematic review

S. Rossell, W. L. Toh, C. Gurvich, 2023, Journal of Neurology.

The Relationship between Negative Symptoms and Both Emotion Management and Non-social Cognition in Schizophrenia Spectrum Disorders

S. Rossell, S. Carruthers, W. L. Toh, 2020, Journal of the International Neuropsychological Society.